29 results
DRS/A
EX-10.13
CTKB
Cytek BioSciences Inc
14 Jun 21
Draft registration statement (amended)
12:00am
and payable for the remainder of this Lease is not sufficient to fully reimburse Lessee on an offset basis, Lessee shall have the right to terminate … , without offset or deduction (except as specifically permitted in this Lease), on or before the day on which it is due. All monetary amounts shall
S-1
EX-10.13
CTKB
Cytek BioSciences Inc
2 Jul 21
IPO registration
4:34pm
and payable for the remainder of this Lease is not sufficient to fully reimburse Lessee on an offset basis, Lessee shall have the right to terminate … , without offset or deduction (except as specifically permitted in this Lease), on or before the day on which it is due. All monetary amounts shall
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
9 May 23
Cytek Biosciences Reports First Quarter 2023 Financial Results
4:24pm
and biotech customers, which was partially offset by stronger revenue growth across the EMEA and APAC regions. On a constant currency basis, total
8-K/A
EX-99.2
lb21ry
15 May 23
Financial Statements and Exhibits
4:03pm
10-Q
17pwidjf6
3 Sep 21
Quarterly report
12:00am
10-K
qgr55w3sdg09prnpzad2
17 Mar 22
Annual report
4:38pm
DRS/A
7lznfef4rurskr 75
14 Jun 21
Draft registration statement (amended)
12:00am
424B4
mj8vb2k nn
23 Jul 21
Prospectus supplement with pricing info
4:12pm
S-1
iot m1e9174
2 Jul 21
IPO registration
4:34pm
S-1/A
8oyt69e
13 Jul 21
IPO registration (amended)
9:03pm